Allosteric Modulation Of G Protein-Coupled Receptors: Opportunities And Challenges For Drug Discovery

Organizers: Andrew Alt (Bristol-Myers Squibb), Jennifer Henry (The New York Academy of Sciences)
Speakers: P. Jeffrey Conn (Vanderbilt University), Christian Felder (Eli Lilly and Company), Adam Hendricson (Bristol-Myers Squibb), Celine Valant (Monash University, Victoria, Australia)
Allosteric modulation of GPCRs as a therapeutic strategy offers improved selectivity and safety. This symposium discusses emerging screening strategies for allosteric modulators and in vitro assessment of allosteric modulator activity.